Addressing the Barrier of Memory Cell Reactivity

Time: 2:00 pm
day: Pre-Conference Day

Details:

• Outlining the importance of the memory T and B cell response in the formation of anti-AAV antibodies
• Evaluating the latest immune tolerance approaches to prevent their formation following a priming dose
• What potential impact does controlling the memory T cell response hold for redosing? 

Speakers:

Genine Winslow Seasoned rare disease and gene therapy drug developer who brings immunology expertise and AAV based gene therapy translation together to address the immune related challenges Read more